Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-068839
Filing Date
2021-05-18
Accepted
2021-05-18 16:09:13
Documents
1
Period of Report
2021-05-14

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2116776-7_4.html 4  
1 OWNERSHIP DOCUMENT tm2116776-7_4.xml 4 6351
  Complete submission text file 0001104659-21-068839.txt   7786
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address
Payne Joseph E (Reporting) CIK: 0001727315 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40034 | Film No.: 21936038

Mailing Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103
Business Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103 (267) 207-3606
Vallon Pharmaceuticals, Inc. (Issuer) CIK: 0001824293 (see all company filings)

EIN.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations